Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ABVX · against 1,336 other Healthcare companies
Ranked #953 of 1,337 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score385 peers with a valuation score of 0–9, including ABVX · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | ABVX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | Not reported | 1.5% | — | — | 30% |
| EBITDA yieldHigher is better · 1,357 reported | -4.5% | 4.2% | 22% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -2.9% | -1.0% | 43% | 20% | |
| Book yieldHigher is better · 1,306 reported | 6.7% | 37.9% | 11% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 953 | 1.3B USD | 8 | 15 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 953 | 3.9B USD | 8 | 47 |
| 953 | 243M USD | 8 | 27 |
| 953 | 1.7B USD | 8 | 23 |
| 953 | 7.7B USD | 8 | 36 |
| 953 | 6.9B EUR (≈$7.6B) | 8 |
| 953 | 693M USD | 8 |
| 953 | 551M USD | 8 | 20 |
| 953 | 198M USD | 8 | 10 |